Latest in Philadelphia chromosome-positive ALL (Ph+ ALL)

Mobile supportive care for children and young adults with ALL

Post-HSCT management of paediatric patients with ALL

Rare inherited pathogenic germline variants observed in sporadic paediatric neuroblastoma cases

COVID-19 pandemic threatens global life-saving gains in childhood cancer

Inotuzumab ozogamicin in paediatric CD22-positive r/r acute lymphoblastic leukaemia: results of the ITCC-059 study

Neurocognitive impairment in long-term survivors of childhood Hodgkin lymphoma

Clinical implications of MRD detection in infants with KMT2A-rearranged ALL Treated on the Interfant-06 protocol

Prospective validation of single mouse testing by the paediatric preclinical testing consortium

Priorities of cancer research in Nepal

Total body radiation vs chemotherapy-based conditioning in children and adolescents with ALL

Venetoclax plus navitoclax in R/R ALL and lymphoblastic lymphoma